Detalhe da pesquisa
1.
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
Prostate
; 78(12): 889-895, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707790